Laboratorio de Investigación en Microbiología Médica y Ambiental, Facultad de Medicina, Universidad Autónoma del Estado de México, Paseo Tollocan esquina Jesús Carranza s/n, 50180 Toluca, México
Auto-generated profile, based on publicly available information
Lorna Catalina Can-Ubando
Laboratorio de Investigación en Microbiología Médica y Ambiental, Facultad de Medicina, Universidad Autónoma del Estado de México, Paseo Tollocan esquina Jesús Carranza s/n, 50180 Toluca, México
Environmental pollution poses serious threats to ecosystems, human health, and overall quality of life. Among the most concerning pollutants are emerging contaminants like nonsteroidal anti-inflammatory drugs (NSAIDs), commonly used in human and veterinary medicine. These drugs and their metabolites are excreted into wastewater systems, where existing treatment methods often fail to eliminate them fully. Due to their persistence in aquatic environments, NSAIDs accumulate, necessitating innovative degradation strategies. Fungal biotransformation offers a promising solution, using the unique metabolic capabilities of unicellular yeasts and filamentous fungi. This review explores the potential of fungi to degrade NSAIDs through various enzymatic and nonenzymatic pathways. It also highlights key challenges and perspectives in the field, such as understanding NSAID-fungal cell wall interactions, the role of transcriptional factors, and the regulatory networks involved in pharmaceutical biodegradation. The goal is to advance fungal-based strategies for more effective NSAID removal from wastewater, contributing to broader environmental remediation efforts.
13 August 2024 in Microbiology Resource Announcements
Nonsteroidal anti-inflammatory drugs (NSAIDs) are emerging contaminants whose bioremediation becomes challenging under multiple environmental stressors. This study evaluates the resilience and NSAID tolerance of Bacillus safensis HS4–2 and Bacillus haynesii TXO1–1SG1. The two strains were isolated from saline-sodium sediment. They were tested independently for tolerance to salinity (0 – 3.4µ M), pH (5–11), and the NSAIDs diclofenac, ibuprofen, and ketoprofen (10, 100, and 1000 µM). Genetic identification was performed using the 16S rRNA gene, followed by whole-genome sequencing with the Illumina and Nanopore platforms, and annotation through RAST. The Strain HS4–2 tolerated 0 – 2.5µ M NaCl, pH 5–11, 10 µM diclofenac, 1000 µM ibuprofen, and 100 µM ketoprofen. The strain TXO1–1SG1 tolerated 0 – 2.5 µM NaCl, pH 5–11, 10 µM diclofenac, 100 µM ibuprofen, and 1000 µM ketoprofen. Both genetic and genomic analyses confirm the species assignments (Bacillus safensis HS4–2, Bacillus haynesii TXO1–1SG1). Genome annotation revealed genes associated with stress response, and aromatic compound metabolism, suggesting their potential role in NSAID transformation, although no analytical validation of degradation was performed. All sequences are available in GenBank. The dataset provides a resource for comparative and functional genomic studies of extremotolerant Bacillus strains in environments with multiple stress conditions.